North America Brachytherapy Devices Market Analysis and Forecast by Size, Share, Growth, Trends 2034

The North America Brachytherapy Devices Market size is expected to reach US$ 711.2 Million by 2034 from US$ 397.0 Million in 2025. The market is estimated to record a CAGR of 6.9% from 2026 to 2034.

Executive Summary and North America Brachytherapy Devices Market Analysis:

The region benefits from the presence of specialized cancer treatment centers, favorable reimbursement frameworks, and continuous investment in oncology research and development. Brachytherapy is widely adopted due to its precision, shorter treatment cycles, and ability to minimize radiation exposure to surrounding healthy tissues.

The US holds the largest share of the market in North America, driven by early adoption of innovative medical technologies and the presence of leading device manufacturers and distributors. Canada contributes steadily through increasing access to modern cancer care and government-supported healthcare initiatives. High-dose-rate (HDR) brachytherapy systems, radioactive seeds, and image-guided treatment solutions remain key areas of technological advancement across the region.

Industry consolidation and strategic partnerships play an important role in shaping the competitive landscape. In January 2021, BEBIG Medical GmbH assumed global production and distribution of HDR brachytherapy products previously managed by Eckert & Ziegler BEBIG GmbH, including Mick Radio-Nuclear Instruments, Inc. This development strengthened supply chain efficiency and product availability, benefiting healthcare providers in North America. In May 2024, GT Medical Technologies partnered with Theragenics Corporation to expand physician access to Cesium-131 brachytherapy seeds. Under the agreement, Theragenics became the exclusive distributor of Cesium-131 seeds and carriers for multiple non-brain cancer treatments, including prostate cancer, supporting clinical adoption.

Ongoing technological innovation, strong distribution networks, and increasing focus on precision oncology sustain growth in the North America brachytherapy devices market, reinforcing its position as a key region for internal radiotherapy solutions.

North America Brachytherapy Devices Market: Strategic Insights

North America Brachytherapy Devices Market Segmentation Analysis:

• By Product, the North America Brachytherapy Devices Market is segmented into Seeds, Brachytherapy Afterloaders and Applicators, and Electronic Brachytherapy. The Brachytherapy Afterloaders and Applicators segment dominated the market in 2025.
• By Type, the North America Brachytherapy Devices Market is segmented into High Dose Rate Brachytherapy Implants and Low Dose Rate Brachytherapy Implants. The Low Dose Rate Brachytherapy Implants segment dominated the market in 2025.
• By Application, the North America Brachytherapy Devices Market is segmented into Breast Cancer, Cervical Cancer, Prostate Cancer, Lung Cancer, and Others. The Prostate Cancer segment dominated the market in 2025.
• By End-user, the North America Brachytherapy Devices Market is segmented into Hospital and Specialty Clinics, Ambulatory Surgical Centers, and Others. The Hospital and Specialty Clinics segment dominated the market in 2025.

North America Brachytherapy Devices Market Players Density: Understanding Its Impact on Business Dynamics

The North America Brachytherapy Devices Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

North America Brachytherapy Devices Market Outlook

According to estimates released by the World Health Organization (WHO) and the International Agency for Research on Cancer (IARC), approximately 20 million new cancer cases and 9.7 million cancer-related deaths were reported globally in 2022. Nearly 53.5 million people were living within five years of a cancer diagnosis, underscoring the expanding need for long-term and advanced cancer care. The data also highlight disparities in cancer outcomes, particularly in underserved populations, and reveal that countries lack adequate financing for cancer and palliative care services.

Brachytherapy has emerged as a vital treatment modality due to its ability to deliver high-dose radiation directly to tumors while minimizing damage to surrounding healthy tissue. This targeted approach is used in the treatment of prostate, cervical, breast, and gynecological cancers, which account for a large share of global cancer cases. As cancer incidence continues to rise, the demand for localized radiation therapies is expected to grow.

Recent developments illustrate this trend. In March 2025, BEBIG Medical's advanced SagiNova brachytherapy system became operational at Father Muller Medical College Hospital, strengthening its oncology services. The system enables precise and cost-effective cancer treatment, improving access to advanced care for underserved communities. The rising cancer prevalence, combined with the need for affordable and high-quality treatment, is driving the adoption of brachytherapy devices worldwide.

North America Brachytherapy Devices Market Country Insights

By country, the North America Brachytherapy Devices Market is segmented into the United States, Canada, and Mexico. The United States held the largest share in 2025.

The country demonstrates strong adoption of brachytherapy procedures due to their clinical effectiveness, shorter hospital stays, and improved patient comfort compared to conventional radiation therapies.

Leading medical device manufacturers and research institutions invest in product innovation and clinical trials to enhance treatment accuracy and efficiency. Strategic partnerships and collaborations are undertaken to expand oncology portfolios and address unmet clinical needs. In February 2024, BD announced a partnership with Camtech Health to advance cervical cancer screening, offering women in Singapore the option to self-collect samples at home, highlighting the global outreach and innovation focus of companies with a strong presence in the US.

Favorable reimbursement policies, increasing awareness of early cancer diagnosis, technological advancements, and a strong focus on comprehensive cancer care drive market growth in the US.

North America Brachytherapy Devices Market Company Profiles

Some of the key players operating in the market include Carl Zeiss Meditec, GE HealthCare Technologies Inc, Elekta AB, Siemens Healthineers AG, Becton Dickinson and Co, Eckert & Ziegler AG, Theragenics Corporation, BEBIG Medical, CIVCO Medical Solutions, and C4 Imaging.

These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.

North America Brachytherapy Devices Market Research Methodology

The following methodology has been followed for the collection and analysis of data presented in this report:

Secondary Research

The research process begins with comprehensive secondary research, utilizing internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:

• Company websites, annual reports, financial statements, broker analyses, and investor presentations
• Industry trade journals and other relevant publications
• Government documents, statistical databases, and market reports
• News articles, press releases, and webcasts specific to companies operating in the market

Note: All financial data included in the Company Profiles section has been standardized to US$. For companies reporting in other currencies, figures have been converted to US$ using the relevant exchange rates for the corresponding year.

Primary Research

The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:

• Validate and refine findings from secondary research
• Enhance the expertise and market understanding of the analysis team
• Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects

Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:

• Industry stakeholders: Vice Presidents, Business Development Managers, Market Intelligence Managers, and National Sales Managers
• External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise